Skip to main content

Peer Review reports

From: MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

Original Submission
1 May 2014 Submitted Original manuscript
8 May 2014 Reviewed Reviewer Report - Yong Han
1 Sep 2014 Reviewed Reviewer Report - Alister Ward
16 Sep 2014 Author responded Author comments - Zsófia Pénzváltó
Resubmission - Version 2
16 Sep 2014 Submitted Manuscript version 2
22 Sep 2014 Author responded Author comments - Zsófia Pénzváltó
Resubmission - Version 3
22 Sep 2014 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
9 Oct 2014 Author responded Author comments - Zsófia Pénzváltó
Resubmission - Version 5
9 Oct 2014 Submitted Manuscript version 5
22 Oct 2014 Author responded Author comments - Zsófia Pénzváltó
Resubmission - Version 6
22 Oct 2014 Submitted Manuscript version 6
Publishing
4 Nov 2014 Editorially accepted
18 Nov 2014 Article published 10.1186/1471-2407-14-837

You can find further information about peer review here.

Back to article page